Press Room

50th Organic Process Research and Development Conference (OPRD)

Start
Monday, October 02, 2023 - 09:00
End
Wednesday, October 04, 2023 - 18:00
Location: Barcelona, Spain
Booth Number: 20

Visit Hovione at OPRD (Table #20), the Leading Process Chemistry Conference from 2-4 October in Barcelona. 
The chemical and pharma industries are fast moving and ever changing and the efficient conversion of a chemical process into a process for manufacture on tonnage scale has always been of importance. However, in the current economic and regulatory climate, it has become increasingly vital and challenging to do so efficiently and sustainably. 

The conference is the place to be to learn about the latest scientific updates in the industry and to network with chemical experts from around the globe.

Schedule a meeting with our experts (Table #20) to learn more about our focus on the development and manufacture of challenging products that demand the highest standards of process chemistry and manufacturing expertise coupled with rigorous regulatory compliance.

 

schedule a meeting

 

Schedule your meeting today 

 

More about Hovione Drug Substance

 

Find more about OPRD Barcelona

 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025